Friday, September 7, 2012
Panel formed to study AYUSH
Panel formed to study AYUSH row
By Sangeetha Samuel - BANGALORE
07th September 2012 10:25 AM
The deadlock over the use of allopathic medicines along with ayurveda by the Bachelor of Ayurveda, Medicine and Surgery (BAMS) doctors may soon end in the state.
A high-power committee, headed by the additional chief secretary, has been constituted to look into the use of the allopathic medicines by ayurveda doctors.
The government has directed the committee to submit a report within 20 days.
The committee also consists of principal secretary of Medical Education, director of Department of AYUSH, vice-chancellor of Rajiv Gandhi University of Health Sciences, secretaries of legal and finance departments, members of IMA and Karnataka Medical Council.
Dr N A Magadum, president of AYUSH Federation of India-Karnataka said it is crucial to use allopathy medicines along with ayurveda especially in emergency cases.
“The use of allopathy is essential in rural areas, as more number of BAMS doctors serve in villages.
In cases of emergency, like in case of dehydration the doctors have to administer IV fluids.
At a situation like this a doctor cannot restrict to ayurveda medicines alone”.
He also cited the example of administering anti-tetanus drug in case of a cut or bruise, which is again an allopathic drug.
He said, that under the Drugs and Cosmetics Act section 2 (ee) BAMS doctors use modern medicines along with ayurveda practises.
“States like Maharashtra, Himachal Pradesh, Andhra Pradesh, Tamil Nadu have already permitted the BAMS doctors to use allopathy medicine,” he said.
As per the instruction from the Apex Court and the Centre, 12 states have been issued government order to permit the usage of allopathic medicine along with ayurveda based on the need of the situation.
Magadum said that if the GO permitting AYUSH doctors to use allopathic medicine is passed then as many as 40,000 ayurveda doctors in the state would benefit.
by The New Indian Express
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment